Oncology & Cancer
Gene fault could predict ovarian cancer drug success
Faults in a gene commonly inactivated in many different types of cancer could be used to predict which drug combination ovarian cancer patients are most likely to benefit from, according to research at Newcastle University.
Jun 6, 2011
0
0
